Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04171037 · ClinicalTrials.gov registry record · NA
Optiflow THRIVE for Delivery of Oxygen to Patients During Total Intravenous Anesthesia While Undergoing Radiology Procedures
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT04171037: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT04171037 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 108 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04171037, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
This trial studies how well Optiflow THRIVE works in delivering oxygen to patients during total intravenous anesthesia while undergoing radiology procedures. The Optiflow THRIVE is an oxygen administration device that delivers high-flow and humidified oxygen through the nose. The Optiflow THRIVE device may improve oxygen delivery and reduce breathing complications.
Interventions
- OTHER Questionnaire Administration
- PROCEDURE Oxygen Therapy
- DEVICE Optiflow THRIVE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2019-10-04 |
| Est. Completion | 2024-06-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04171037
The ClinicalTrials.gov registry entry for NCT04171037 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT04171037 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04171037 about?
NCT04171037 is a clinical study titled "Optiflow THRIVE for Delivery of Oxygen to Patients During Total Intravenous Anesthesia While Undergoing Radiology Procedures". This trial studies how well Optiflow THRIVE works in delivering oxygen to patients during total intravenous anesthesia while undergoing radiology procedures. The Optiflow THRIVE is an oxygen administration device that delivers high-flow and humidified oxygen through the nose. The Optiflow THRIVE dev...
What is the current status of trial NCT04171037?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2019-10-04. Estimated completion is 2024-06-21.
What interventions are being tested in trial NCT04171037?
The interventions under investigation include: Questionnaire Administration (OTHER), Oxygen Therapy (PROCEDURE), Optiflow THRIVE (DEVICE).
Who is sponsoring clinical trial NCT04171037?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.